| Product Code: ETC13117518 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of pneumococcal vaccines to India in 2024 saw a notable increase in concentration levels, shifting from moderate to high concentration, as per the Herfindahl-Hirschman Index (HHI). The top exporting countries to India in 2024 were the USA, Denmark, China, Sweden, and South Korea. Despite a significant decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024 at -22.7%, the growth rate for 2023 to 2024 plummeted even further to -49.05%. This indicates a challenging market environment for pneumococcal vaccine imports in India, with potential implications for industry players and stakeholders.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pneumococcal Vaccines Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 India Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 India Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 India Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 India Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in India |
4.2.2 Government initiatives to improve immunization coverage |
4.2.3 Growing healthcare infrastructure and investments in preventive healthcare |
4.3 Market Restraints |
4.3.1 High cost of pneumococcal vaccines |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 Vaccine hesitancy and lack of awareness among some population segments |
5 India Pneumococcal Vaccines Market Trends |
6 India Pneumococcal Vaccines Market, By Types |
6.1 India Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 India Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 India Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 India Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 India Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 India Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 India Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 India Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 India Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 India Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 India Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 India Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 India Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 India Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 India Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 India Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 India Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 India Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 India Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 India Pneumococcal Vaccines Market Export to Major Countries |
7.2 India Pneumococcal Vaccines Market Imports from Major Countries |
8 India Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Number of vaccination campaigns conducted by the government |
8.2 Percentage increase in vaccination coverage rates |
8.3 Number of healthcare facilities offering pneumococcal vaccines |
8.4 Rate of adoption of new vaccine technologies in the market |
8.5 Number of reported cases of pneumococcal diseases in India |
9 India Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 India Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 India Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Pneumococcal Vaccines Market - Competitive Landscape |
10.1 India Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 India Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here